Intellia Therapeutics, Inc.

Some of the best links we picked up around the internet

CMN Weekly (23 May 2025) - Your Weekly CRISPR...

CMN Weekly

May. 23, 2025

Some of the best links we picked up around the internet

CMN Weekly (9 May 2025) - Your Weekly CRISPR...

CMN Weekly

May. 9, 2025

Some of the best links we picked up around the internet

CMN Weekly (4 April 2025) - Your Weekly CRISPR...

CMN Weekly

Apr. 4, 2025

Some of the best links we picked up around the internet

CMN Weekly (28 March 2025) - Your Weekly CRISPR...

CMN Weekly

Mar. 28, 2025

Some of the best links we picked up around the internet

CMN Weekly (7 March 2025) - Your Weekly CRISPR...

CMN Weekly

Mar. 7, 2025

Some of the best links we picked up around the internet

CMN Weekly (28 February 2025) - Your Weekly CRISPR...

CMN Weekly

Feb. 28, 2025

Some of the best links we picked up around the internet

CMN Weekly (24 January 2025) - Your Weekly CRISPR...

CMN Weekly

Jan. 24, 2025

Some of the best links we picked up around the internet

Intellia Therapeutics, Inc.

Transthyretin Amyloidosis with Polyneuropathy, ATTRv-PN, (NCT06672237)
Sponsors:
Intellia Therapeutics

IND Enabling

Phase I

Phase II

Phase III

Hereditary Angioedema, HAE, (NCT06634420)
Sponsors:
Intellia Therapeutics

IND Enabling

Phase I

Phase II

Phase III

Alpha-1 Antitrypsin Deficiency, AATD, (NCT06622668)
Sponsors:
Intellia Therapeutics

IND Enabling

Phase I

Phase II

Phase III

Hemophilia B, (NCT06379789)
Sponsors:
Regeneron Pharmaceuticals

IND Enabling

Phase I

Phase II

Phase III

Hereditary Angioedema, HAE, (NCT06262399)
Sponsors:
Intellia Therapeutics

IND Enabling

Phase I

Phase II

Phase III

Transthyretin Amyloidosis, ATTR, (NCT05697861)
Sponsors:
Intellia Therapeutics

IND Enabling

Phase I

Phase II

Phase III

Transthyretin Amyloidosis, ATTR, (NCT06128629)
Sponsors:
Intellia Therapeutics

IND Enabling

Phase I

Phase II

Phase III

Hereditary Angioedema, HAE, (NCT05120830)
Sponsors:
Intellia Therapeutics

IND Enabling

Phase I

Phase II

Phase III